Otolaryngology

Clinical evidence, research, and medical intelligence in Otolaryngology.

Supported OTC Hearing Aids Outperform Self-Fitting in Older Adults

A randomized trial found structured support improved outcomes with over-the-counter hearing aids versus self-fitting in older adults with hearing loss.

By Dr. A. Nikhil Krishnan, MBBS · Oct 26, 2026 · 5 min read

Otolaryngology·BMJ Open

Acupuncture Network Meta-Analysis Protocol for Sudden Sensorineural Hearing Loss

BMJ Open protocol outlines a network meta-analysis of acupuncture-related therapies for sudden sensorineural hearing loss using audiometric and…

Oct 25, 2026

Otolaryngology·PubMed

Rhinosinusitis Risk in Adults on TNF-Alpha and Anti-CD20 Therapy

A scoping review examines rhinosinusitis in adults treated with TNF-alpha inhibitors and anti-CD20 therapy, where immune suppression may…

Oct 24, 2026

Otolaryngology·DailyMed

Pseudoephedrine 120 mg label details nasal decongestant warnings and dosing

DailyMed’s updated pseudoephedrine HCl 120 mg label lists dosing, contraindications, storage rules, and key warnings for decongestion use.

Oct 23, 2026

Otolaryngology·DailyMed

Neomycin-Polymyxin B-Hydrocortisone Otic Label Warns on Ototoxicity

DailyMed labeling for neomycin, polymyxin B, and hydrocortisone otic solution details otitis externa use, 10-day limits, and ototoxicity…

Oct 23, 2026

Otolaryngology·DailyMed

Oxymetazoline nasal spray label reinforces short-term congestion relief

DailyMed’s updated oxymetazoline label reiterates short-term nasal decongestion, dosing limits, rebound risk, and warnings for cardiovascular and endocrine…

Oct 23, 2026

Otolaryngology·DailyMed

Mucinex Sinus-Max label details triple-action congestion relief and liver warnings

DailyMed label details for Mucinex Sinus-Max list acetaminophen, guaifenesin, and phenylephrine with dosing limits, liver warnings, and age…

Oct 23, 2026

Otolaryngology·DailyMed

Fluticasone Nasal Spray Label Adds Safety Focus on Eye and Mucosal Risks

DailyMed labeling for fluticasone propionate nasal spray details pediatric use, dosing, and warnings on mucosal injury, ocular effects,…

Oct 21, 2026

Otolaryngology·PLOS ONE

Hearing Loss Progression in Midlife Linked to Metabolic and Environmental Factors

A six-year cohort study in middle-aged adults found worsening hearing tied to age, sex, smoking, obesity, hypertension, pre-diabetes,…

Oct 20, 2026

Otolaryngology·BBC Dental

Vaping and Voice Changes: Selena Gomez Describes Nicotine’s Impact

Selena Gomez says nicotine vaping changed her voice, while clinicians continue to weigh airway irritation, addiction risk, and…

Oct 20, 2026

Otolaryngology

Clinical evidence, research, and medical intelligence in Otolaryngology.

In Brief The 5-minute rounds

New hypertension guideline lowers the treatment threshold to 130/80 mm Hg.
Phase 3 GLP-1 trial reports a 20% cut in major adverse cardiac events.
FDA clears a next-generation CAR-T therapy for relapsed lymphoma.
Meta-analysis links early mobilisation to shorter ICU length of stay.
Rapid guidance broadens empiric antibiotics for suspected sepsis.